Valence Discovery

About This Business

Valence Discovery, located in Montreal, Quebec, is a cutting-edge research entity focused on revolutionizing the field of drug discovery through the power of artificial intelligence. As the AI research engine of Recursion, Valence Discovery leverages a unique set of industry-leading ingredients, including access to Recursion's platform, data, and computing infrastructure, to develop innovative ways to predict, explain, and ultimately decode biology. The primary objective of drug discovery is to accurately infer the effects of treatments on patients, and Valence Discovery aims to achieve this by creating computational models that can accurately predict patient responses to interventions. This would enable practitioners to safely and economically test and optimize a wide range of therapeutic hypotheses before starting human clinical trials. Furthermore, the development of virtual cells that can accurately predict the functional response of a wide variety of cells to genetic and chemical interventions would be of tremendous value in designing effective and safe therapeutics. Valence Discovery's vision is to create a transformative platform for drug discovery, and the company is well-positioned to achieve this goal due to recent advances in machine learning, computational power, and data generation. The company has introduced TxPert, a state-of-the-art model that leverages multiple biological knowledge networks to simulate cellular functional responses. With its strong foundation in AI research and commitment to innovation, Valence Discovery is poised to make a significant impact in the field of drug discovery and improve patient outcomes. The company's approach is centered around the development of agentic systems that continuously refine the mechanistic understanding of human physiology, and its research is guided by key modeling considerations, evaluation benchmarks, and a roadmap for future research. As a leader in the field of AI-powered drug discovery, Valence Discovery is dedicated to advancing the frontiers of biomedical research and improving human health. With its unique approach and cutting-edge technology, the company is an exciting player in the biotech industry, and its work has the potential to revolutionize the way drugs are discovered and developed. By combining the power of AI with the expertise of its research team, Valence Discovery is creating a new paradigm for drug discovery, one that is faster, more efficient, and more effective. As the company continues to push the boundaries of what is possible in the field of AI-powered drug discovery, it is likely to have a profound impact on the biotech industry and beyond.